DSV Expands Air ThermoDirect Network with Direct Shanghai Connections to Global Pharmaceutical Hubs
DSV is expanding its global temperature-controlled air freight network with a new direct connection between Luxembourg and Shanghai Pudong International Airport (PVG), strengthening the logistics company’s ability to support pharmaceutical and healthcare supply chains across Europe and Asia. The expansion also forms part of DSV’s broader plans to introduce additional connections to the United States, further increasing the reach of its Air ThermoDirect solution.
The new service responds to growing demand for dependable, temperature-controlled transportation for pharmaceutical products and other healthcare shipments that require carefully managed environmental conditions throughout the logistics process.
As pharmaceutical manufacturers increasingly operate global supply chains, the transportation of temperature-sensitive medicines, vaccines, biologics and other healthcare products has become more complex. Maintaining appropriate temperature conditions during air transportation is essential because exposure to unsuitable conditions can affect product quality and, in some cases, compromise the integrity of high-value healthcare products.
DSV’s expanded Air ThermoDirect network is designed to provide customers with a more direct and controlled transportation option. The new Luxembourg-to-Shanghai connection gives DSV a dedicated link between an important European logistics hub and one of Asia’s major international air cargo gateways.
Direct Connectivity Between Luxembourg and Shanghai
At the center of the expansion is a new direct air freight connection between Luxembourg and Shanghai Pudong International Airport.
The operation is supported by multiple departures using dedicated freighter aircraft. This operating model gives DSV greater control over scheduling, routing and cargo handling, which can be particularly important when transporting pharmaceutical products that are sensitive to delays and environmental fluctuations.
Direct connectivity can also reduce the number of transfer points involved in a shipment’s journey. Every additional handling stage can introduce operational complexity, particularly for temperature-sensitive cargo. By establishing a direct connection, DSV can create a more streamlined transportation process between Europe and China.
The Luxembourg-Shanghai route also strengthens DSV’s ability to connect pharmaceutical manufacturers and healthcare businesses with major markets in Greater China and the wider Asian region.
For customers managing international healthcare supply chains, predictable transportation is a critical requirement. Pharmaceutical shipments often involve strict delivery schedules, regulatory requirements and product-specific temperature ranges. A network designed around dedicated air freight capacity can provide greater predictability while supporting the specialized handling needs of these shipments.
Shanghai as a Strategic Pharmaceutical Logistics Hub
Shanghai Pudong International Airport plays an important role in international air cargo transportation and serves as a significant gateway for pharmaceutical and healthcare products entering and leaving China.
The airport’s position within the broader Shanghai logistics ecosystem makes it an important connection point for international manufacturers, healthcare companies and distributors seeking access to the Chinese and Asian markets.By strengthening its Air ThermoDirect presence at PVG, DSV is expanding its ability to support both inbound and outbound pharmaceutical cargo flows.
The development is particularly relevant as pharmaceutical companies continue to globalize manufacturing and distribution networks. Healthcare products may travel across several countries before reaching patients, hospitals, pharmacies or other end users. Maintaining consistent logistics standards throughout that journey is therefore increasingly important.
DSV’s expanded network is intended to provide customers with a specialized transportation solution that combines direct air connectivity with temperature-controlled handling capabilities.
Supporting Growing Demand for Pharmaceutical Logistics
The pharmaceutical logistics market has become increasingly sophisticated as the industry develops more temperature-sensitive products.Traditional pharmaceutical products often require controlled ambient conditions, while certain advanced medicines can require much tighter temperature management. Biologics and other specialized healthcare products can be particularly sensitive to temperature variations.
This means logistics providers must deliver more than basic transportation. They need to provide processes and infrastructure capable of protecting cargo throughout the journey.
DSV’s Air ThermoDirect solution is designed around this requirement. The company is expanding the network to address demand for temperature-controlled air freight while providing customers with greater flexibility in how pharmaceutical products are transported internationally.
The Luxembourg-to-Shanghai connection is therefore more than a new air cargo route. It represents an expansion of specialized logistics infrastructure aimed at supporting the increasingly complex requirements of global healthcare supply chains.
Greater Control Over Transportation Operations
One of the key advantages of DSV’s new setup is the additional level of operational control provided by dedicated freighter operations.
Using dedicated aircraft for multiple departures gives the logistics provider greater influence over flight schedules and cargo movements. This can help improve predictability for customers shipping products that must reach their destinations within defined timeframes.
For pharmaceutical companies, schedule reliability can be especially important. Delays can create challenges for inventory planning, production schedules and downstream distribution.A more controlled transportation process can help reduce unnecessary uncertainty and provide customers with greater visibility into the movement of their products.
The direct connection between Luxembourg and Shanghai also creates a more focused transportation corridor between Europe and Asia, supporting the movement of pharmaceutical cargo in both directions.
Specialized Ground Handling in Shanghai
DSV’s Air ThermoDirect expansion is supported by its partnership with Eastern Air Logistics (EAL), which provides specialized ground-handling facilities in Shanghai.Ground handling is a critical component of pharmaceutical logistics because temperature control must be maintained not only during flight but also during airport processing and transfers.
A temperature-controlled shipment can be exposed to risks while being unloaded, stored, inspected or transferred between transportation modes. Specialized infrastructure and handling procedures can therefore play an important role in protecting cargo integrity.The collaboration with EAL is intended to provide the infrastructure required to support Air ThermoDirect operations at Shanghai Pudong International Airport.
The setup is further supported by GHA partner China Eastern Logistics Cold Chain Ltd., adding dedicated cold-chain expertise and infrastructure to the operation.Together, these partnerships strengthen the handling capabilities available to DSV customers shipping temperature-sensitive pharmaceutical products through Shanghai.
Modular Thermal Packaging
Another important feature of DSV’s Air ThermoDirect offering is its use of modular thermal packaging solutions.The approach reduces reliance on active temperature-controlled containers and traditional passive packaging systems. Instead, modular thermal packaging can provide a more flexible solution for different shipment requirements.
This flexibility can be valuable for pharmaceutical logistics because cargo volumes, product specifications and transportation requirements can vary significantly between shipments.A modular approach can also support scalability. As pharmaceutical companies expand their international distribution networks, they may need logistics solutions that can adapt to changing shipment volumes and destinations.
DSV’s packaging approach is designed to provide temperature protection while potentially improving transportation efficiency and cost management.
Improving Cost Efficiency
Temperature-controlled logistics can be expensive because pharmaceutical shipments may require specialized containers, handling infrastructure and additional monitoring.By using modular thermal packaging and reducing dependence on certain active and passive packaging solutions, DSV aims to create a more cost-efficient approach to temperature-controlled air freight.
Lower operating costs can be important for pharmaceutical manufacturers and distributors that are managing increasingly complex global supply chains.The ability to combine temperature control with direct transportation can also help reduce logistical complexity. Fewer transfer points may mean fewer handling stages and potentially lower exposure to operational disruptions.For customers, the objective is to balance product protection, service reliability, flexibility and cost efficiency.
Sustainability in the Cold Chain
DSV is also highlighting the environmental benefits of its reusable thermal packaging program.Traditional cold-chain logistics can generate significant packaging requirements because temperature-sensitive products often require specialized insulation and protective materials.
Reusable thermal packaging provides an opportunity to reduce packaging waste by allowing equipment to be used across multiple shipments.DSV says its sustainable reusable thermal packaging program is designed to reduce packaging waste and improve the environmental performance of cold-chain logistics.
Sustainability is becoming an increasingly important consideration for pharmaceutical and healthcare companies. As businesses seek to reduce the environmental impact of their supply chains, logistics providers are under pressure to develop solutions that combine operational performance with more sustainable practices.Reusable packaging can contribute to that objective while maintaining the temperature protection required for sensitive products.
Building a Stronger Healthcare Supply Chain
Kenneth Kallström, Executive Vice President and Global Enterprise Vertical Head for Healthcare at DSV, described the expansion as a strategic gateway to Greater China and the broader Asian market.
According to Kallström, the initiative is intended to help customers improve supply-chain efficiency, reduce operating costs and protect the integrity of critical healthcare products across one of the world’s fastest-growing regions.
The executive also emphasized the role of DSV’s reusable thermal packaging program in reducing packaging waste and improving the environmental performance of cold-chain logistics.The comments highlight DSV’s broader strategy of integrating transportation infrastructure, specialized handling and sustainability initiatives into its healthcare logistics offering.
Rather than treating air transportation as an isolated service, the company is building a connected logistics solution that extends from airport handling to packaging and temperature management.
Importance of Supply Chain Resilience
Supply chain resilience has become a major priority for pharmaceutical companies.Global healthcare supply chains can be affected by transportation disruptions, capacity constraints, geopolitical developments, weather events and other unforeseen circumstances. A resilient logistics network requires multiple capabilities, including reliable transportation, specialized facilities and effective contingency planning.
Direct air freight connections can contribute to resilience by providing dedicated capacity and reducing dependence on multiple intermediate connections.
The new Luxembourg-Shanghai service strengthens DSV’s network across an important international trade corridor. Additional planned routes to the United States could further extend the company’s ability to connect major pharmaceutical markets.
This expansion could give healthcare customers more options when designing international distribution networks and managing temperature-sensitive products.
Connecting Europe, China and Global Healthcare Markets
The new service strengthens Luxembourg’s role within DSV’s global air freight network while enhancing Shanghai’s position as a strategic gateway for pharmaceutical cargo.
Europe and China are major centers of pharmaceutical production, research and healthcare consumption. Reliable transportation links between these markets are therefore important for manufacturers, distributors and other organizations involved in healthcare supply chains.
The direct connection provides a dedicated transportation option for companies moving temperature-sensitive products between Europe and China.As DSV develops additional U.S. connections, the network could become increasingly relevant for pharmaceutical companies operating global supply chains across Europe, Asia and North America.
A More Flexible Approach to Temperature-Controlled Air Freight
DSV’s Air ThermoDirect expansion reflects a broader evolution in pharmaceutical logistics.Customers increasingly require transportation solutions that offer reliability without creating unnecessary complexity or excessive costs. At the same time, they are looking for logistics partners capable of supporting sustainability objectives and meeting stringent pharmaceutical handling requirements.
The combination of direct freighter connectivity, specialized ground handling, modular thermal packaging and reusable packaging initiatives is intended to address these needs.The approach gives DSV an opportunity to differentiate its temperature-controlled air freight services by focusing on both operational performance and supply chain efficiency.
The expansion of DSV’s Air ThermoDirect network is expected to strengthen the company’s position in temperature-controlled pharmaceutical logistics.The new Luxembourg-to-Shanghai connection establishes a direct link between two important logistics markets while providing additional infrastructure for pharmaceutical cargo moving into and out of China.
The company’s partnerships with Eastern Air Logistics and China Eastern Logistics Cold Chain Ltd. add specialized ground-handling capabilities in Shanghai, while modular thermal packaging provides flexibility in managing temperature-sensitive shipments.The planned expansion into additional U.S. routes could further increase the network’s global reach.
For pharmaceutical and healthcare companies, the development comes at a time when reliable, resilient and sustainable logistics solutions are becoming increasingly important. As pharmaceutical supply chains become more international and products become more temperature-sensitive, specialized transportation infrastructure will play a growing role in ensuring that medicines and other healthcare products reach their destinations safely and efficiently.
DSV’s latest investment demonstrates how logistics providers are adapting to these changing requirements. By combining direct air connectivity with temperature-controlled handling and reusable packaging, the company is seeking to provide a more integrated solution for the global healthcare sector.
Ultimately, the expansion of Air ThermoDirect strengthens DSV’s ability to support critical pharmaceutical supply chains across Europe, China and, with future route additions, other major global healthcare markets. The initiative also illustrates the growing convergence of air freight, cold-chain logistics, supply chain resilience and sustainability, as companies seek transportation solutions capable of meeting both operational and environmental priorities.
Source link: https://www.dsv.com/